Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1958 1
1965 1
1966 1
1967 1
1968 2
1969 3
1970 2
1971 3
1974 1
1975 4
1976 6
1977 10
1978 4
1979 4
1980 7
1981 10
1982 8
1983 11
1984 10
1985 9
1986 16
1987 4
1988 10
1989 15
1990 13
1991 9
1992 9
1993 6
1994 4
1995 12
1996 11
1997 7
1998 7
1999 16
2000 17
2001 18
2002 27
2003 17
2004 24
2005 22
2006 24
2007 31
2008 37
2009 36
2010 33
2011 33
2012 41
2013 53
2014 45
2015 39
2016 43
2017 47
2018 47
2019 91
2020 111
2021 81
2022 104
2023 100
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

1,215 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab: A Review of Present Indications and Off-Label Uses.
Muñoz-Bellido FJ, Moreno E, Dávila I. Muñoz-Bellido FJ, et al. J Investig Allergol Clin Immunol. 2022 Apr 19;32(2):97-115. doi: 10.18176/jiaci.0682. Epub 2021 Mar 3. J Investig Allergol Clin Immunol. 2022. PMID: 33661102 Free article. Review.
New possible indications are increasingly explored and include skin diseases, such as prurigo nodularis, nummular eczema, allergic contact dermatitis, chronic hand eczema, spontaneous chronic urticaria, bullous pemphigoid, alopecia areata, and Netherton syndrome, as …
New possible indications are increasingly explored and include skin diseases, such as prurigo nodularis, nummular eczema, allergic contact d …
Acute and Chronic Urticaria: Evaluation and Treatment.
Schaefer P. Schaefer P. Am Fam Physician. 2017 Jun 1;95(11):717-724. Am Fam Physician. 2017. PMID: 28671445 Free article. Review.
Diagnosis is made clinically; anaphylaxis must be ruled out. Chronic urticaria is idiopathic in 80% to 90% of cases. Only a limited nonspecific laboratory workup should be considered unless elements of the history or physical examination suggest specific underlying …
Diagnosis is made clinically; anaphylaxis must be ruled out. Chronic urticaria is idiopathic in 80% to 90% of cases. Only a li …
Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria.
Maurer M, Berger W, Giménez-Arnau A, Hayama K, Jain V, Reich A, Haemmerle S, Lheritier K, Walsh P, Xia S, Storim J. Maurer M, et al. J Allergy Clin Immunol. 2022 Dec;150(6):1498-1506.e2. doi: 10.1016/j.jaci.2022.08.027. Epub 2022 Sep 9. J Allergy Clin Immunol. 2022. PMID: 36096203 Free article. Clinical Trial.
Remibrutinib, a highly selective, oral, novel covalent Bruton tyrosine kinase inhibitor, might be effective in CSU. OBJECTIVE: This first-in-patient trial aimed to evaluate the efficacy and safety of remibrutinib in CSU treatment and characterize the dose-response. METHODS …
Remibrutinib, a highly selective, oral, novel covalent Bruton tyrosine kinase inhibitor, might be effective in CSU. OBJECTIVE: This first-in …
New treatments for chronic urticaria.
Kolkhir P, Altrichter S, Munoz M, Hawro T, Maurer M. Kolkhir P, et al. Ann Allergy Asthma Immunol. 2020 Jan;124(1):2-12. doi: 10.1016/j.anai.2019.08.014. Epub 2019 Aug 23. Ann Allergy Asthma Immunol. 2020. PMID: 31446134 Review.
OBJECTIVE: Chronic urticaria (CU) is a common, heterogeneous, and debilitating disease. ...We also searched ClinicalTrials.gov for recent and ongoing randomized clinical trials in CU. STUDY SELECTIONS: Relevant articles were selected and reviewed. ...
OBJECTIVE: Chronic urticaria (CU) is a common, heterogeneous, and debilitating disease. ...We also searched ClinicalTrials.gov …
Pathophysiology, Diagnosis, and Management of Chronic Spontaneous Urticaria: A Literature Review.
Greiner B, Nicks S, Adame M, McCracken J. Greiner B, et al. Clin Rev Allergy Immunol. 2022 Dec;63(3):381-389. doi: 10.1007/s12016-022-08952-y. Epub 2022 Sep 1. Clin Rev Allergy Immunol. 2022. PMID: 36048326 Review.
Novel therapies, among others discussed here, are rapidly being developed with new trials and therapeutics being released nearly monthly. Thus, we performed a scoping literature review of randomized controlled trials studying targeted therapies for CSU. We also discuss the …
Novel therapies, among others discussed here, are rapidly being developed with new trials and therapeutics being released nearly monthly. Th …
Current and future management of chronic spontaneous urticaria and chronic inducible urticaria.
Do TT, Canty EA, Joshi SR. Do TT, et al. Allergy Asthma Proc. 2023 Jan 1;44(1):3-14. doi: 10.2500/aap.2023.44.220093. Allergy Asthma Proc. 2023. PMID: 36719690 Review.
Background: Chronic urticaria (CU), characterized by 6 weeks of intense pruritus, remains a debilitating condition for patients. ...Methods: A literature search via a medical literature data base and clinical trial data base was conducted to identify t …
Background: Chronic urticaria (CU), characterized by 6 weeks of intense pruritus, remains a debilitating condition for patient …
Safety of Biologics for Atopic Diseases During Pregnancy.
Shakuntulla F, Chiarella SE. Shakuntulla F, et al. J Allergy Clin Immunol Pract. 2022 Dec;10(12):3149-3155. doi: 10.1016/j.jaip.2022.08.013. Epub 2022 Aug 18. J Allergy Clin Immunol Pract. 2022. PMID: 35987486 Free PMC article. Review.
Most publications found were case reports, case series, or observational studies reporting outcomes in a total of 313 pregnancies. No randomized controlled studies were identified. We found that biologics do not seem to influence maternal or fetal outcomes. ...
Most publications found were case reports, case series, or observational studies reporting outcomes in a total of 313 pregnancies. No ran …
Chronic Urticaria: An Overview of Treatment and Recent Patents.
Hon KL, Leung AKC, Ng WGG, Loo SK. Hon KL, et al. Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):27-37. doi: 10.2174/1872213X13666190328164931. Recent Pat Inflamm Allergy Drug Discov. 2019. PMID: 30924425 Free PMC article. Review.
METHODS: The search strategy included meta-analyses, randomized controlled trials, clinical trials, reviews and pertinent references. Patents were searched using the key term "chronic urticaria" at the following links: www.google.com/patents, www.uspto …
METHODS: The search strategy included meta-analyses, randomized controlled trials, clinical trials, reviews and pertinent refe …
Chronic Urticaria.
Hsu JI, Hsu S. Hsu JI, et al. Skinmed. 2022 Oct 31;20(5):364-366. eCollection 2022. Skinmed. 2022. PMID: 36314703
A thorough history and physical examination are vital for accurate diagnosis of chronic urticaria. Extended laboratory tests rarely yield clinically significant or actionable findings, and hence are not recommended. ...
A thorough history and physical examination are vital for accurate diagnosis of chronic urticaria. Extended laboratory tests r …
Chronic Urticaria.
Hsu JI, Hsu S. Hsu JI, et al. Skinmed. 2022 Oct 31;20(4):364-366. eCollection 2022. Skinmed. 2022. PMID: 36314621
A thorough history and physical examination are vital for accurate diagnosis of chronic urticaria. Extended laboratory tests rarely yield clinically significant or actionable findings, and hence are not recommended. ...
A thorough history and physical examination are vital for accurate diagnosis of chronic urticaria. Extended laboratory tests r …
1,215 results